Consistent with the c-MYC/Mcl1 prevention model (Figure 2, A and B), the AFP immunization also prevented cMet/β-catenin-induced HCC tumor formation (Supplemental Figure 23, A C, and D, P < 0.05). This evidence concerns the gene MCL1 and hepatocellular carcinoma.